Large Bowel Cancer in Women in Relation to Reproductive and Hormonal Factors: a Case-control Study
Overview
Authors
Affiliations
A community-based case-control study of the effect of reproductive factors on risk of large bowel cancer in Australia is described. The study involved 155 cases (99 colon cancer, 56 rectal cancer) and 311 controls who were interviewed with regard to pregnancies and their outcomes, lactation, menstrual history, and oral contraceptive (OC) use. Increasing parity was associated with a decreasing risk of colon cancer; para 0, relative risk (RR)=1; para 1-2, RR=0.9, 95% confidence interval (CI)=0.4-1.8; para greater than or equal to 3, RR=0.4, 95% CI=0.2-0.8; later age at first live birth (AFLB) was associated with increasing risk (AFLB less than or equal to 21 yr, RR=1; 22-25 yr, RR=2.3, 95% CI=1.0-5.5; greater than or equal to 26 yr, RR=2.7, 95% CI=1.2-6.2). These effects were independent of each other. Parity appeared to exert its predominant effect on risk of cancer of the right colon. OC use was more common among controls than cases (RR=0.5; 95% CI=0.3-1.2 for ever vs. never users) and showed a dose-response effect in multiple logistic analysis. The pattern of point-estimate RR for rectal cancer was largely congruent with those for colon cancer but was not significantly different from 1.0.
Genetic risk impacts the association of menopausal hormone therapy with colorectal cancer risk.
Tian Y, Lin Y, Qu C, Arndt V, Baurley J, Berndt S Br J Cancer. 2024; 130(10):1687-1696.
PMID: 38561434 PMC: 11091089. DOI: 10.1038/s41416-024-02638-2.
Colorectal Cancer Chemoprevention: A Dream Coming True?.
Lepore Signorile M, Grossi V, Fasano C, Simone C Int J Mol Sci. 2023; 24(8).
PMID: 37108756 PMC: 10140862. DOI: 10.3390/ijms24087597.
Role of anabolic agents in colorectal carcinogenesis: Myths and realities (Review).
Krasanakis T, Nikolouzakis T, Sgantzos M, Mariolis-Sapsakos T, Souglakos J, Spandidos D Oncol Rep. 2019; 42(6):2228-2244.
PMID: 31578582 PMC: 6826302. DOI: 10.3892/or.2019.7351.
Hormone receptor expression of colorectal cancer diagnosed during the peri-partum period.
Silverstein J, Kidder W, Fisher S, Hope T, Maisel S, Ng D Endocr Connect. 2019; 8(8):1149-1158.
PMID: 31370007 PMC: 6686950. DOI: 10.1530/EC-19-0063.
A prospective study of oral contraceptive use and colorectal adenomas.
Charlton B, Giovannucci E, Fuchs C, Chan A, Lee J, Cao Y Cancer Causes Control. 2016; 27(6):749-57.
PMID: 27125831 PMC: 5177026. DOI: 10.1007/s10552-016-0752-3.